Regeneron wins bid to buy 23andMe out of bankruptcy
Bio Pharma Dive
MAY 19, 2025
The biotech, which has for years invested in genetics research, plans to acquire "substantially all" of testing firm 23andMe's assets for $256 million.
Mon.May 19, 2025
289 
MHRA approves guselkumab for Crohn’s disease and ulcerative colitis
Pharma Times
MAY 19, 2025
Regulator confirms safety and efficacy of new treatment option for patient
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA OKs first blood test to aid Alzheimer’s diagnosis
Bio Pharma Dive
MAY 19, 2025
The FDA cleared the test for early detection of amyloid plaques associated with Alzheimer’s in people aged 55 years and older with signs and symptoms of the disease.
Apnimed to seek approval for sleep apnoea pill after Phase III success
Pharmaceutical Technology
MAY 19, 2025
Apnimed will be waiting for the readout from a second Phase III trial before it approaches the FDA with an NDA for the sleep apnoea pill.
How to Turn “Check-the-Box” Compliance Trainings Into Real Learning
Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group
Let’s face it—most ethics and compliance training programs aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, captivating, and maybe even enjoyable! Join learning design expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training. We'll explore innovative strategies to bring traditionally dry topics to life, making them resonate with learners and drive tangible change.
Revolutionizing the Fight Against Biologic Drug Patent Thickets
Drug Patent Watch
MAY 19, 2025
"Breaking the Chains of Exorbitant Medication Costs: How a New Approach to Biologic Drug Patents Could Save Lives and Billions As the cost of life-saving medications continues to skyrocket, a growing number of patients are being priced out of the healthcare system. But what if there was a way to unlock the secrets of biologic drug patents, making these critical treatments more accessible and affordable for all?
ATS 2025: Nucala reduces COPD exacerbations, regardless of severe event history
Pharmaceutical Technology
MAY 19, 2025
At ATS 2025, data from the Phase III MATINEE trial reinforced the efficacy of Nucala in reducing exacerbations in COPD patients.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Power of collaboration more pertinent than ever says pharma experts
Pharmaceutical Technology
MAY 19, 2025
At a recent gathering, experts in the Swiss biotech and pharma sector underscored the power of international collaboration.
From insight to impact: How eCOAs strengthen trial data quality
Bio Pharma Dive
MAY 19, 2025
Timely, high-integrity insights for sponsors that reduce risk and move trials forward.
FDA approves Incyte’s retifanlimab combo for SCAC treatment
Pharmaceutical Technology
MAY 19, 2025
The US FDA has approved Incytes Zynyz (retifanlimab-dlwr) in conjunction with carboplatin and paclitaxel (platinum-based chemo).
Judge shuts down drugmakers’ 340B rebate plans, for now
Bio Pharma Dive
MAY 19, 2025
A district court ruled HHS has the power to review drugmakers’ plans to pay hospitals rebates on 340B medications. But it left the door open to the controversial reforms.
Clinical Research White Paper – Enhancing Transparency & Efficiency Throughout the Trial Lifecycle
Advertisement
Enhancing Transparency & Efficiency Throughout the Trial Lifecycle for AI Readiness
Novo Nordisk’s CEO to step down as weight loss market share plummets
Pharmaceutical Technology
MAY 19, 2025
Novo Nordisk stated that replacing Jrgensen is "in the best interests of the company and its shareholders"
Bridging the data gaps that impact retail and specialty-lite success
Bio Pharma Dive
MAY 19, 2025
Learn how to leverage predictive analytics and measure top KPIs to maximize patient outcomes, provider engagement and brand performance on this webinar from PHIL and Syneos Health.
Five years, one approval: Europe’s slow march on Alzheimer’s treatments
Pharmaceutical Technology
MAY 19, 2025
In April 2025, the European Medicines Agency (EMA) approved Eisai and Biogens Leqembi for early-stage Alzheimers disease, marking Europes first major nod for a disease-modifying Alzheimers therapy in over a decade.
How regulatory convergence is raising the bar for sterile drug safety—and how West leads the way
Bio Pharma Dive
MAY 19, 2025
Global regulators continue to raise the bar on sterile drug manufacturing—and West is responding.
Can Your Organization Spot a Conflict Before It’s a Crisis?
Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk
In today’s complex healthcare environment, navigating third-party relationships has become even more challenging—whether it’s vendor relationships, employee activities, or patient-facing interactions. Left unmanaged, these conflicts can compromise trust, regulatory compliance, and even organizational reputation. So, how can healthcare teams stay ahead?
Leading with Purpose: Novotech’s CEO on Diversity, Innovation, and Global Expansion
Pharmaceutical Technology
MAY 19, 2025
Explore Novotech CEO John Moller's insights on the company's global expansion, commitment to diversity, and innovative approaches in clinical research. Discover how Novotech is shaping the future of clinical trials with a focus on inclusivity and technological advancement.
Ensuring Regulatory Compliance When Using Wearables in Clinical Trials
Crucial Data Soutions
MAY 19, 2025
Regulatory Risks of Wearables in Clinical Trials Are Real (and Avoidable) Wearables have become indispensable in modern clinical trials, tracking. The post Ensuring Regulatory Compliance When Using Wearables in Clinical Trials appeared first on Crucial Data Solutions.
Pharmaceutical Technology Excellence Awards 2025: Imagene
Pharmaceutical Technology
MAY 19, 2025
Imagene is the Innovation award winner in the Precision Oncology category in the 2025 Pharmaceutical Excellence Awards.
LogiPharma Europe 2025: Inside Sanofi’s Shift Toward a Data-Driven Supply Chain Model
Pharmaceutical Commerce
MAY 19, 2025
Ruth Beadle, head, global supply chain, Sanofi, discusses the companys multi-year effort to build an AI-powered, end-to-end supply chain focused on improving service, resilience, and cost efficiency.
White Paper - A Roadmap to AI Data Readiness in R&D Labs
Advertisement
Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.
Regeneron swoops on genetic testing firm 23andMe
pharmaphorum
MAY 19, 2025
DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal
Prescribing Red Flags: Pharmacists Be Wary of What the Doctor Orders
FDA Law Blog
MAY 19, 2025
By Larry K. Houck Last month the U.S. Attorneys Office for the Northern District of Illinois announced that Walgreens agreed to pay up to $350,000,000 to resolve allegations that its pharmacies illegally filled millions of invalid prescriptions for opioids and other controlled substances in violation of the federal Controlled Substances Act, and sought payment for filling many of those prescriptions by federal health care programs, violating the False Claims Act.
Japan follows UK in GSK's comeback tour for Blenrep
pharmaphorum
MAY 19, 2025
The revitalisation of GSK's blood cancer therapy Blenrep continues with a second approval, in Japan, as a second-line treatment for multiple myeloma
AI-Powered Portfolio Management in Pharmaceuticals
Drug Patent Watch
MAY 19, 2025
"Revolutionizing the Pharmaceutical Industry: How AI-Powered Portfolio Management is Changing the Game As the pharmaceutical landscape continues to evolve, companies are under increasing pressure to optimize their portfolios and stay ahead of the competition. But with the average cost of bringing a new drug to market soaring to over $2 billion, the stakes have never been higher.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
EAPs: Market access outside of the US and Western Europe
pharmaphorum
MAY 19, 2025
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Cem Zorlular, CEO of Er-Kim Pharmaceuticals, a company that has been serving as a regional affiliate for pharma and biotech since 1981 in the CEE and Mediterranean.
Invensify, Go2 Delivery Collaborate on Temperature-Controlled Courier Service
Pharmaceutical Commerce
MAY 19, 2025
The partnership is centered around cutting cold chain costs and emissions with smart packaging and carbon-neutral same-day delivery.
Tariff turbulence: Navigating US trade shifts in the medtech supply chain
pharmaphorum
MAY 19, 2025
Weve seen recent tariff policy changes creating an increasingly volatile environment for exporters and importers alike, particularly those in the medical device and IVD sectors.
Pharma Pulse 5/19/25: Navigating the Payer-Health System Nexus: A Strategic Imperative for Biopharma Commercial Success; Advocate for Change to Address Pharmacy Burnout
Pharmaceutical Commerce
MAY 19, 2025
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Partner of ex-Theranos CEO raising cash for testing start-up
pharmaphorum
MAY 19, 2025
The partner of disgraced ex-Theranos CEO Elizabeth Holmes, Billy Evans, has reportedly raised millions of dollars for another blood testing startup
Recovery Doesn’t Look the Same for Everyone. That’s Why Researchers Want to Hear From You
Trialfacts
MAY 19, 2025
Contents About the Study Why Participate? Your Rights Who Can Participate? About the Research Center Study Location Research Center: University of South Florida Location: 4202 E Fowler Ave, Tampa, FL 33620, United States Lead Researcher: Robert C. Schlauch, Ph.D. IRB: This study has been reviewed and approved by the IRB (STUDY004687) at the University of South Florida and is supported/sponsored by the National Institute of Health (NIH), the National Institute on Alcohol Abuse and Alcoholism (NIA
How Tap Native’s ‘Bid-by-NPI’ Is Transforming Pharma Marketing Precision
Pharma Marketing Network
MAY 19, 2025
In 2015, the idea of targeting individual healthcare professionals (HCPs) through real-time digital bidding felt more like science fiction than strategy. Yet for RJ Lewis, CEO of eHealthcare Solutions and co-founder of Tap Native, it was a logical extension of precision marketing trends emerging in other sectors. He envisioned a world where pharmaceutical brands could assign value at the individual prescriber leveljust as search marketers had long bid on keywords.
Powered by Purpose: Celebrating Clinical Trials Day 2025
Pfizer
MAY 19, 2025
Powered by Purpose: Celebrating Clinical Trials Day 2025 kimkevin Mon, 05/19/2025 - 09:10 Powered by Purpose: Celebrating Clinical Trials Day 2025 Tuesday, May 20, 2025 - 09:00am Share Pfizer has been in the business of breakthroughs for nearly two centuries, and while our success represents the shared work of thousands of our dedicated employees, none of the advancements for which we are known were made possible through our efforts alone.
Let's personalize your content